Aio Pharma

20/04/2025

Fitaro Semaglutide is a prescription medication that helps control appetite, boost metabolism, and support long-term weight management. Backed by clinical studies, this GLP-1 receptor agonist is a scientifically proven solution for adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions.

Struggling to lose stubborn weight despite diet and exercise? Fitaro® (Semaglutide) is a breakthrough prescription medication designed to support sustainable weight loss and improved metabolic health. Trusted by healthcare professionals, Fitaro® helps curb cravings, reduce appetite, and promote healthier blood sugar levels—so you can focus on lasting results.

20/04/2025

Approved by global health authorities, this generic alternative to Opzelura™ Cream offers the same efficacy at an affordable price.

https://aiopharma.com/product/rutinib-cream-30-gm-ruxolitinib-cream/

14/04/2025

𝐓𝐢𝐫𝐳𝐞𝐩𝐚𝐭𝐢𝐝𝐞, the revolutionary dual-action medication designed to help adults manage type 2 diabetes and achieve significant weight loss. As the first and only FDA-approved GLP-1 and GIP receptor agonist, Tirzepatide/Tizaro offers a unique, science-backed approach to improving your overall well-being.

𝙒𝙝𝙮 𝘾𝙝𝙤𝙤𝙨𝙚 𝙏𝙞𝙧𝙯𝙚𝙥𝙖𝙩𝙞𝙙𝙚?

𝐃𝐮𝐚𝐥 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐢𝐧 𝐎𝐧𝐞 𝐈𝐧𝐣𝐞𝐜𝐭𝐢𝐨𝐧: Tirzepatide works by activating both GLP-1 and GIP receptors, helping to regulate blood sugar levels and promote weight loss simultaneously.

𝐏𝐫𝐨𝐯𝐞𝐧 𝐑𝐞𝐬𝐮𝐥𝐭𝐬: Clinical studies show Tirzepatide users experience improved A1C levels and an average weight loss of up to 15% or more.

𝐖𝐞𝐞𝐤𝐥𝐲 𝐂𝐨𝐧𝐯𝐞𝐧𝐢𝐞𝐧𝐜𝐞: Just one injection per week fits seamlessly into your lifestyle, eliminating the need for daily medications.
Appetite Control: Reduces hunger and cravings, making it easier to stick to healthy eating habits and maintain long-term weight loss.

𝙒𝙝𝙤 𝙄𝙨 𝙏𝙞𝙧𝙯𝙚𝙥𝙖𝙩𝙞𝙙𝙚 𝙁𝙤𝙧?
Adults with type 2 diabetes looking for better blood sugar control.
Individuals seeking a clinically proven solution for sustainable weight loss.
Anyone tired of complicated treatment plans and ready for a simple, effective weekly solution.
for more visit https://aiopharma.com/.../tirzepatide-injection-dual.../

30/03/2025

Struggling to lose stubborn weight despite diet and exercise? Fitaro® (Semaglutide) is a breakthrough prescription medication designed to support sustainable weight loss and improved metabolic health. Trusted by healthcare professionals, Fitaro® helps curb cravings, reduce appetite, and promote healthier blood sugar levels—so you can focus on lasting results.

Why Fitaro® Works

✅ Powerful Appetite Control – Acts on brain receptors to reduce hunger and increase feelings of fullness.
✅ Clinically Effective – Studies show significant weight loss results when combined with lifestyle changes.
✅ Blood Sugar Balance – Originally developed for type 2 diabetes, it supports healthier glucose metabolism.
✅ Weekly Convenience – Easy-to-use injectable pen for consistent dosing.

Why Choose Fitaro® Semaglutide?

✔ Clinically Proven Weight Loss – Reduces hunger and promotes fullness for sustainable results.
✔ FDA-Approved Compound – Same active ingredient as leading weight-loss medications.
✔ Improved Blood Sugar Control – Supports healthy glucose metabolism.
✔ Convenient Weekly Injections – Easy-to-use pre-filled pens for consistent dosing.
✔ Doctor-Supervised Treatment – Personalized dosing for optimal safety and effectiveness.

How to use:

The starting dose is 0.25 mg Semaglutide once weekly. After 4 weeks the dose should be increased to 0.5 mg once weekly. After at least 4 weeks with a dose of 0.5 mg once weekly, the dose can be increased to 1 mg once weekly to further improve glycemic control. Weekly doses higher than 1 mg are not recommended. Semaglutide is to be administered once weekly at any time of the day with or without meals. Semaglutide is to be injected subcutaneously in the abdomen, thigh or in upper arm. The injection site can be changed without dose adjustment. Semaglutide should not be administered intravenously or intramuscularly. The day of weekly administration can be changed if necessary as long as the time between two doses is at least 3 days (>72 hours). After selecting a new dosing day, once weekly dosing should be continued.

for more visit https://aiopharma.com/product/fitaro-semaglutide-clinically-proven-weight-management-support/

25/03/2025

belongs to the group of medicines called antineoplastic (cancer medicines). It works by interfering with the growth of cancer cells, which are eventually destroyed.

for more information, please visit https://aiopharma.com/product/osimert-80-mg-osimertinib/

21/03/2025

𝐓𝐢𝐫𝐳𝐞𝐩𝐚𝐭𝐢𝐝𝐞, the revolutionary dual-action medication designed to help adults manage type 2 diabetes and achieve significant weight loss. As the first and only FDA-approved GLP-1 and GIP receptor agonist, Tirzepatide/Tizaro offers a unique, science-backed approach to improving your overall well-being.

𝙒𝙝𝙮 𝘾𝙝𝙤𝙤𝙨𝙚 𝙏𝙞𝙧𝙯𝙚𝙥𝙖𝙩𝙞𝙙𝙚?

𝐃𝐮𝐚𝐥 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐢𝐧 𝐎𝐧𝐞 𝐈𝐧𝐣𝐞𝐜𝐭𝐢𝐨𝐧: Tirzepatide works by activating both GLP-1 and GIP receptors, helping to regulate blood sugar levels and promote weight loss simultaneously.

𝐏𝐫𝐨𝐯𝐞𝐧 𝐑𝐞𝐬𝐮𝐥𝐭𝐬: Clinical studies show Tirzepatide users experience improved A1C levels and an average weight loss of up to 15% or more.

𝐖𝐞𝐞𝐤𝐥𝐲 𝐂𝐨𝐧𝐯𝐞𝐧𝐢𝐞𝐧𝐜𝐞: Just one injection per week fits seamlessly into your lifestyle, eliminating the need for daily medications.
Appetite Control: Reduces hunger and cravings, making it easier to stick to healthy eating habits and maintain long-term weight loss.

𝙒𝙝𝙤 𝙄𝙨 𝙏𝙞𝙧𝙯𝙚𝙥𝙖𝙩𝙞𝙙𝙚 𝙁𝙤𝙧?

Adults with type 2 diabetes looking for better blood sugar control.
Individuals seeking a clinically proven solution for sustainable weight loss.
Anyone tired of complicated treatment plans and ready for a simple, effective weekly solution.

for more visit https://aiopharma.com/product/tirzepatide-injection-dual-action-diabetes-weight-loss-solution/

29/01/2025

May this year illuminate your journey to divinity and spiritual enlightenment. Wishing you a prosperous and joyful Chinese New Year filled with love, happiness, and success.

15/12/2024

27/09/2024

Ivosenib 250 mg is a breakthrough targeted therapy used to treat Acute Myeloid Leukemia (AML). It is specifically designed for patients with a susceptible mutation in the IDH1 gene, offering a tailored approach to tackling this aggressive form of blood cancer. Ivosenib works by inhibiting the IDH1 enzyme, which plays a critical role in producing abnormal blood cells in AML patients, slowing down or stopping cancer cell growth.

https://aiopharma.com/product/ivosenib-250-mg-ivosidenib/

07/11/2023

Apalutamide 60 mg (Prostaxen) is an androgen receptor inhibitor (ARi) that is used to treat men with prostate cancer. It works by blocking the effects of androgens, which are male hormones that can promote the growth of prostate cancer cells.

https://aiopharma.com/product/apalutamide-60-mg-prostaxen/

07/11/2023

Bangladesh has successfully developed and launched Bevixa, a biosimilar of Avastin, a widely used cancer treatment drug. This achievement marks a milestone in the country's growing biopharmaceutical industry and holds immense promise for improving access to affordable and quality cancer care for Bangladeshi patients.

Bangladesh has made significant strides in healthcare with the development of Bevixa, a biosimilar of Avastin, a widely used cancer treatment drug.